Trial Search Results

A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and History of Cardiovascular Disease

COORDINATE-Diabetes is a cluster-randomized clinical trial to test the effectiveness of an innovative, clinic-level educational intervention to improve the management of patients with type 2 diabetes mellitus and cardiovascular disease.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Duke University

Collaborator: Boehringer Ingelheim

Stanford Investigator(s):

Intervention(s):

  • Other: Intense Education Intervention

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Age ≥ 18 years old

   - Diagnosis of Type 2 diabetes mellitus (T2DM)

   - History of at least one of the following conditions:

      1. Coronary artery disease (defined as prior MI, coronary revascularization (CABG or
      PCI), and/or obstructive CAD (≥50%) as documented by angiography or CTA)

      2. Stroke and/or carotid artery stenosis (≥50%)

      3. Peripheral Arterial disease (defined as claudication with ABI<0.9, prior
      peripheral revascularization, and/or amputation due to circulatory insufficiency)

   - Ability to communicate with site staff and understand and provide written informed
   consent and proof of Health Insurance Portability and Accountability Act (HIPAA)
   authorization

Exclusion Criteria:

   - Determined to be highly unlikely to survive and/or to continue follow-up in that
   clinic for at least 1 year, as identified by site investigator

   - GFR<30 mL/min/1.73m2

   - Already on all guideline-recommended therapies for T2DM and CVD

   - Absolute contraindication to any of the guideline recommended therapies for T2DM and
   CVD

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Chiara Orlando
650-721-8437
Recruiting